Labels:crt screen | dialog box | monitor | sky | window OCR: Glycoprotein inhibitors Bottom line Only consistent benefit with Reopro in USA/NQWMI together with PTCA and Stent placement Other agents in USA/NOW /MI without PTCA lack compelling evidence for global benefit Likely benefit sickest patients onlv (likely to undergo PTCA Benefit in transmural MI seen only combination with thromboly rties LMWH see ENTIRE trial) Foot note: recs likely change when Stent-based studies come out Glvcoprotein benefi shown transmura seer tofe whet stett bases cone